title: Thiazolidinediones and clinical diabetes management: new challenges for the fall of 2007.
authors.affiliation: Department of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87111,USA. pboyle@salud.unm.edu
authors.forename: Patrick
authors.initials: P
authors.lastname: Boyle
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000401:mortality*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000139:chemically induced*; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D000077154:Rosiglitazone; D045162:Thiazolidinediones